mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 27 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 60.6% | ‑2.1 / 33.3 | 33 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 3,171,107 | 0 | C | A | 60.0% | ‑1.3 / 10.2 | 10 | E55* (GAG→TAG) | nudF | ADP‑ribose diphosphatase |
| * | NZ_CP009273 | 2,955,854 | 0 | T | G | 59.1% | 12.1 / 19.0 | 22 | S90S (TCA→TCC) | ppdC | prepilin‑type N‑terminal cleavage/methylation domain‑containing protein |
| * | NZ_CP009273 | 15,382 | 0 | A | G | 58.3% | 1.3 / 10.4 | 12 | intergenic (+84/‑63) | dnaJ/BW25113_RS00080 | molecular chaperone DnaJ/IS4‑like element IS421 family transposase |
| * | NZ_CP009273 | 760,181 | 0 | G | C | 58.3% | 4.0 / 13.6 | 12 | P182P (CCG→CCC) | sucD | succinate‑‑CoA ligase subunit alpha |
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 57.6% | ‑0.0 / 34.3 | 33 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 765,675 | 0 | A | C | 55.0% | 11.1 / 19.1 | 21 | T748P (ACC→CCC) | mngB | mannosylglycerate hydrolase |
| * | NZ_CP009273 | 3,493,428 | 0 | T | G | 54.5% | 17.7 / 21.7 | 22 | L54V (TTA→GTA) | frlA | fructoselysine/psicoselysine transporter |
| * | NZ_CP009273 | 108,785 | 0 | A | C | 54.2% | 20.0 / 21.7 | 24 | V101G (GTA→GGA) | zapD | cell division protein ZapD |
| * | NZ_CP009273 | 822,963 | 0 | T | G | 53.8% | ‑2.5 / 12.4 | 13 | D492A (GAC→GCC) | ybhF | ATP‑binding cassette domain‑containing protein |
| * | NZ_CP009273 | 832,048 | 0 | T | G | 53.8% | 7.9 / 11.2 | 13 | V81G (GTC→GGC) | hcxB | hydroxycarboxylate dehydrogenase HcXB |
| * | NZ_CP009273 | 1,819,313 | 0 | G | A | 53.8% | ‑0.1 / 12.7 | 13 | intergenic (‑119/+84) | ves/spy | environmental stress‑induced protein Ves/ATP‑independent periplasmic protein‑refolding chaperone Spy |
| * | NZ_CP009273 | 453,640 | 0 | T | G | 53.3% | 6.1 / 11.4 | 15 | G253G (GGT→GGG) | clpX | ATP‑dependent protease ATP‑binding subunit ClpX |
| * | NZ_CP009273 | 3,623,890 | 0 | A | C | 53.3% | 7.8 / 12.9 | 15 | W25G (TGG→GGG) | yhiI | HlyD family efflux transporter periplasmic adaptor subunit |
| * | NZ_CP009273 | 4,527,926 | 0 | A | C | 53.3% | 5.7 / 14.4 | 15 | G219G (GGT→GGG) | nanM | N‑acetylneuraminate epimerase |
| * | NZ_CP009273 | 2,775,868 | 0 | A | C | 52.9% | 10.6 / 18.9 | 17 | V73G (GTA→GGA) | ypjA | adhesin‑like autotransporter YpjA/EhaD |
| * | NZ_CP009273 | 3,401,190 | 0 | C | G | 52.6% | 11.5 / 22.8 | 19 | G75G (GGC→GGG) | panF | sodium/pantothenate symporter |
| * | NZ_CP009273 | 4,612,067 | 0 | A | G | 52.4% | 14.1 / 23.2 | 21 | E161G (GAG→GGG) | yjjJ | type II toxin‑antitoxin system HipA family toxin YjjJ |
| * | NZ_CP009273 | 3,659,062 | 0 | C | A | 45.0% | 28.8 / 11.0 | 20 | A37S (GCG→TCG) | gadX | acid resistance transcriptional activator GadX |
| * | NZ_CP009273 | 4,292,512 | 0 | G | A | 44.4% | 20.3 / 11.5 | 27 | V128V (GTC→GTT) | mdtO | multidrug efflux transporter permease subunit MdtO |
| Marginal new junction evidence (sorted from low to high skew) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NZ_CP009273 | 548215 = | 23 (1.160) | 4 (0.250) | 4/132 | 1.1 | 18.8% | coding (342/510 nt) | purE | 5‑(carboxyamino)imidazole ribonucleotide mutase |
| ? | NZ_CP009273 | 548231 = | 16 (1.010) | coding (326/510 nt) | purE | 5‑(carboxyamino)imidazole ribonucleotide mutase | |||||